Search

TRGFT-201

[L64070] It is a precision-engineered graft composed of three cell populations isolated from an HLA-matched donor's mobilized peripheral blood — purified hematopoietic stem and progenitor cells (HSPCs) … [L64070,L64071] It is the first regulatory T cell (Treg)-based immunotherapy approved by the FDA.[L64071]

Melengestrol

Melengestrol is a steroidal progestin and antineoplastic agent which was never marketed. An acylated derivative, melengestrol acetate, is used as a growth promoter in animals.

KT-A261

KT-A261 is an adeno-associated viral vector serotype 2 (AAV2) encoded to express adalimumab. It is being investigated for the treatment of noninfectious uveitis.

Anethole

LIS-1

LIS-1 is an immunoglobulin G (IgG) polyclonal antibody that binds to human T cells.

RGG0853

RGG0853 is an E1A lipid complex, a repressor gene complexed with a cationic lipid vector.

Brolucizumab

[L9089] Brolucizumab was granted FDA approval in October 2019.[L9089] … Brolucizumab, also known as RTH258 or ESBA1008,[A187211] is a monoclonal antibody indicated to treat neovascular age related macular degeneration.

NY-ESO-1 peptide vaccine

NY-ESO-1 peptide vaccine is an investigational cancer immunotherapy. It contains a peptide derived from the cancer-testis antigen (NY-ESO-1).

NM-702

M-702 is an orally active inhibitor of phosphodiesterase and thromboxane synthetase. … It is estimated that about 6 million people suffer from intermittent claudication in the USA, with only 10 percent of these people currently receiving treatment.

N-(3-carboxypropanoyl)-L-norvaline

These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. … N-(3-carboxypropanoyl)-L-norvaline is a solid. This compound belongs to the n-acyl-alpha amino acids.